NASDAQ:DTIL

Precision Biosciences Stock Predictions

Healthcare > Biotechnology

Buy DTIL

*Your capital is at risk

$6.04

-0.280 (-4.43%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

DTIL Prediction Chart

DTIL Predictions History

Latest community submissions for DTIL.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
PredictionBot.Kathy Pro	Jul 21, 2025	$4.50 -2.44%	$4.65	X	96.72%	0
PredictionBot.Warren Pro	Jul 21, 2025	$4.68 +1.52%	$4.65	V	99.35%	4
fxkeefe	Jul 21, 2025	Bullish	$4.65	V	—	1
creditfixnow.com.339041	Aug 11, 2022	Bullish	$1.63	X	—	0
JS Pro	Dec 15, 2020	$7.86 -96.73%	$8.01	V	98.19%	1
CORealtor Merchant	Dec 15, 2020	$8.04 -96.65%	$8.01	X	99.56%	4
JS Pro	Dec 9, 2019	$20.40 -92.84%	$9.50	X	0.00%	0
Christopher Hoak @ChristopherHoak.129667	Dec 9, 2019	Bearish	$9.50	V	—	1
PolarBear.117899	Sep 24, 2019	$8.35 -97.22%	$10.03	V	83.25%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for DTIL with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT PRECISION BIOSCIENCES INC.

Precision BioSciences, Inc., a clinical stage gene editing company, develops vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. The company operates through two segments, Therapeutic and Food. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which a specific type of immune cell, called a T cell, is genetica...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by